Clinical Trial Participation and COVID-19: a Descriptive Analysis from the American Heart Association ’s Get With The Guidelines Registry

We examined patients hospitalized with COVID-19 at centers participating in the American Heart Association ’s COVID-19 CVD Registry. The primary outcome was odds of enrollment in a clinical trial, according to sex, race, and ethnicity. Among 14,397 adults hospitalized with COVID-19, 9.5% (n = 1,377) were enrolled in a clinical trial. The proportion of enrolled patients was the lowest for Black patients (8%); in multivariable analysis, female and Black patients were less likely to be enrolled in a clinical trial related to COVID-19 compared to men and other racial groups, respectiv ely. Determination of specific reasons for the disparities in trial participation related to COVID-19 in these populations should be further investigated.
Source: Journal of Racial and Ethnic Health Disparities - Category: International Medicine & Public Health Source Type: research